Diseases

Using our unique disease and affordability forecasting model we are able to forecast the burden of a disease and the affordable market.

  • Burden of disease: the number of people by age and gender and geography with a particular disease or health condition.
  • Affordable market: of those with disease how many can afford treatment if fully or partially self financed.

This is ideal for assessing new product entry, optimizing performance of current portfolio, pricing and R&D strategy (demand for specific therapies in the future).

The forecast model allows any disease or health condition to be assessed ranging from breast cancer to diabetes, from pulmonary hypertension to obesity and potential smokers wanting to quit.

Disease forecasts are provided in the following to ways:

Reports

  1. Disease Burden Report: This report series details the disease burden profile of a region and how this may change over the next 20 years, allowing the reader to identify the dominant therapy needs and market potential for different products within their product portfolio. First the demographic and socioeconomic factors that influence the disease burden profile are outlined including age structure, urbanization and affluence, in terms of GDP, income distribution and healthcare expenditure. This is followed by forecasts of a selection of different disease/therapy types; the forecast includes disease rates, number of people with the disease, age/ gender and where possible urban/rural profile, and how this changes yearly to 2030.
    Price US$4,950 Available for most countries.
    Available soon.

  2. Cancer Burden Report: This report series details the cancer burden profile of a region and how this may change over the next 20 years, allowing the reader to identify the dominant cancer types and the need for different products within their oncology portfolio. First the demographic and socioeconomic factors that influence the cancer burden profile are outlined including age structure, urbanization and affluence, in terms of GDP, income distribution and healthcare expenditure. This is followed by forecasts of a selection of different cancer types; the forecast includes disease rates, number of people with the disease, age/ gender and where possible urban/rural profile, and how this changes yearly to 2030.
    Price US$4,950 Available for most countries.
    Available soon.

  3. Disease Affordable Market Report: This report series profiles the number of people who have a particular disease or health condition, e.g. diabetes, and of these how many may be able to access/afford a treatment or diagnostic, by different prices by region over the next 2 decades. It allows the reader to identify the market size of a product that targets a particular disease in terms of value, volume and growth potential. An outline of the target groups by age and gender is included, plus analysis of the impact of different prices and reimbursement on value and volume. For details of the disease types available please go to our shop. If there is a particular therapy area for which there is no report, please contact us directly as analysis can be conducted through customizing our model- PharmaForecast.
    Price US$3,900. Available for most countries.
    Available soon.

Customized Epidemiology & Affordable Market Forecast Models

PharmaForecast is a unique interactive therapy forecasting model that provides epidemiology (disease) and affordable market size and value forecasts for over 70 countries and in China by 31 Provinces and 2178 Cities and in India by 32 States.

These epidemiology and affordability forecasts can help you with new product planning, portfolio optimization, and pricing strategy by:

  • Identifying the number of people in the target region with a particular health condition and how this will change over time, given the historic trends and disease rates.
  • Identifying of those who can afford treatment for a given condition and how this will change over time, taking into account increasing affluence of a society.
  • Testing the impact of different pricing on the market size and value.
  • Yearly from 2000 to 2030.

You can choose from 3 options:

  1. Epidemiology (Disease or health condition) only.
  2. Epidemiology (Disease or Health Condition), Affordable market and Pricing analysis.
  3. Epidemiology (Disease or Health Condition), Affordable market, Sales analysis and product expansion planning.

What you get: Therapy forecasts yearly from 2000-2030, a customized, detailed Report of 50-70 PowerPoint slides and the interactive therapy area forecast model provided in Excel, which can easily be incorporated into other in house models. The Excel models are in the same format for all 70 geographies and allows detailed assessment of "what if" scenarios.

Contact us directly by clicking here